Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese
Multiple SGLT2 inhibitors have been approved to treat adults with CKD over the past 5 years, and in 2021, the nonsteroidal mineralocorticoid receptor antagonist finerenone (Kerendia, Bayer) was approved to lower risk for renal and CV complications for adults with type 2 diabetes and CKD
Goldbaum GM, Kendrick JS, Hogelin GC, Gentry EM
Long-term follow-up data from cardiovascular outcomes trials indicate that any early increase in retinopathy events tends to plateau over time, and the overall trajectory of retinal health may ultimately be favorable due to sustained improvements in glycemic control
Visit our website, go to klinic.com/membership choose the service you need (e.g., weight loss or addiction treatment), and book an appointment with one of our healthcare professionals